The gold standard for prostate cancer diagnosis is based on histopathological evaluation of prostate biopsy, an invasive procedure associated with discomfort, distress, and severe complications, due to the elevated serum PSA level and suspicious DRE. This evidence concerns the gene KLK3 and Familial prostate cancer.